nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00755	0.267	CbGeAlD
Zuclopenthixol—HTR2A—pulmonary artery—systemic scleroderma	0.00535	0.189	CbGeAlD
Zuclopenthixol—HTR2A—artery—systemic scleroderma	0.00198	0.07	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—systemic scleroderma	0.00167	0.0592	CbGeAlD
Zuclopenthixol—HTR2A—blood vessel—systemic scleroderma	0.00154	0.0546	CbGeAlD
Zuclopenthixol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Zuclopenthixol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Zuclopenthixol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Zuclopenthixol—Shock—Lisinopril—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Neutropenia—Prednisone—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Tachycardia—Lisinopril—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Abdominal pain—Azathioprine—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Body temperature increased—Azathioprine—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Zuclopenthixol—Skin disorder—Lisinopril—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Diarrhoea—Captopril—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Zuclopenthixol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Prednisone—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Nausea—Mometasone—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Zuclopenthixol—Anorexia—Lisinopril—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Weight increased—Prednisone—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Ataxia—Methotrexate—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Pain—Mycophenolic acid—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Constipation—Mycophenolic acid—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00104	CcSEcCtD
Zuclopenthixol—Weight decreased—Prednisone—systemic scleroderma	0.00101	0.00103	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.001	0.00103	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Prednisone—systemic scleroderma	0.001	0.00103	CcSEcCtD
Zuclopenthixol—Hypotension—Lisinopril—systemic scleroderma	0.000994	0.00102	CcSEcCtD
Zuclopenthixol—Dizziness—Captopril—systemic scleroderma	0.000994	0.00102	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000992	0.00102	CcSEcCtD
Zuclopenthixol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00099	0.00102	CcSEcCtD
Zuclopenthixol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00102	CcSEcCtD
Zuclopenthixol—Abdominal pain—Leflunomide—systemic scleroderma	0.000979	0.00101	CcSEcCtD
Zuclopenthixol—Body temperature increased—Leflunomide—systemic scleroderma	0.000979	0.00101	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000974	0.001	CcSEcCtD
Zuclopenthixol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000973	0.001	CcSEcCtD
Zuclopenthixol—Breast disorder—Methotrexate—systemic scleroderma	0.000971	0.000999	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00097	0.000998	CcSEcCtD
Zuclopenthixol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000969	0.000998	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000966	0.000994	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000966	0.000994	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000966	0.000994	CcSEcCtD
Zuclopenthixol—Insomnia—Lisinopril—systemic scleroderma	0.000963	0.000991	CcSEcCtD
Zuclopenthixol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000961	0.000989	CcSEcCtD
Zuclopenthixol—Paraesthesia—Lisinopril—systemic scleroderma	0.000956	0.000983	CcSEcCtD
Zuclopenthixol—Vomiting—Captopril—systemic scleroderma	0.000955	0.000983	CcSEcCtD
Zuclopenthixol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000951	0.000979	CcSEcCtD
Zuclopenthixol—Dyspnoea—Lisinopril—systemic scleroderma	0.000949	0.000976	CcSEcCtD
Zuclopenthixol—HRH1—connective tissue—systemic scleroderma	0.000948	0.0335	CbGeAlD
Zuclopenthixol—Rash—Captopril—systemic scleroderma	0.000947	0.000975	CcSEcCtD
Zuclopenthixol—Dermatitis—Captopril—systemic scleroderma	0.000947	0.000974	CcSEcCtD
Zuclopenthixol—Somnolence—Lisinopril—systemic scleroderma	0.000946	0.000974	CcSEcCtD
Zuclopenthixol—Headache—Captopril—systemic scleroderma	0.000941	0.000969	CcSEcCtD
Zuclopenthixol—Dyspepsia—Lisinopril—systemic scleroderma	0.000937	0.000964	CcSEcCtD
Zuclopenthixol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000934	0.000961	CcSEcCtD
Zuclopenthixol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000934	0.000961	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000932	0.00096	CcSEcCtD
Zuclopenthixol—ADRA2A—connective tissue—systemic scleroderma	0.000931	0.0329	CbGeAlD
Zuclopenthixol—Decreased appetite—Lisinopril—systemic scleroderma	0.000925	0.000952	CcSEcCtD
Zuclopenthixol—Eosinophilia—Methotrexate—systemic scleroderma	0.00092	0.000946	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000919	0.000946	CcSEcCtD
Zuclopenthixol—Fatigue—Lisinopril—systemic scleroderma	0.000917	0.000944	CcSEcCtD
Zuclopenthixol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000917	0.000944	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000914	0.000941	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000913	0.00094	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000912	0.000939	CcSEcCtD
Zuclopenthixol—Constipation—Lisinopril—systemic scleroderma	0.00091	0.000937	CcSEcCtD
Zuclopenthixol—Pain—Lisinopril—systemic scleroderma	0.00091	0.000937	CcSEcCtD
Zuclopenthixol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00091	0.000937	CcSEcCtD
Zuclopenthixol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000906	0.000932	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000901	0.000928	CcSEcCtD
Zuclopenthixol—Diarrhoea—Azathioprine—systemic scleroderma	0.000897	0.000923	CcSEcCtD
Zuclopenthixol—Nausea—Captopril—systemic scleroderma	0.000893	0.000919	CcSEcCtD
Zuclopenthixol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000889	0.000915	CcSEcCtD
Zuclopenthixol—Asthenia—Leflunomide—systemic scleroderma	0.000889	0.000914	CcSEcCtD
Zuclopenthixol—Pancytopenia—Methotrexate—systemic scleroderma	0.000882	0.000908	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000877	0.000902	CcSEcCtD
Zuclopenthixol—Pruritus—Leflunomide—systemic scleroderma	0.000876	0.000902	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000874	0.0009	CcSEcCtD
Zuclopenthixol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000871	0.000897	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00087	0.000896	CcSEcCtD
Zuclopenthixol—Dysuria—Methotrexate—systemic scleroderma	0.000869	0.000894	CcSEcCtD
Zuclopenthixol—Neutropenia—Methotrexate—systemic scleroderma	0.000869	0.000894	CcSEcCtD
Zuclopenthixol—HRH1—smooth muscle tissue—systemic scleroderma	0.000867	0.0306	CbGeAlD
Zuclopenthixol—Dizziness—Azathioprine—systemic scleroderma	0.000867	0.000892	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000855	0.00088	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000849	0.000874	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000848	0.000873	CcSEcCtD
Zuclopenthixol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000848	0.000872	CcSEcCtD
Zuclopenthixol—Diarrhoea—Leflunomide—systemic scleroderma	0.000847	0.000872	CcSEcCtD
Zuclopenthixol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000843	0.000868	CcSEcCtD
Zuclopenthixol—Abdominal pain—Lisinopril—systemic scleroderma	0.000841	0.000866	CcSEcCtD
Zuclopenthixol—Body temperature increased—Lisinopril—systemic scleroderma	0.000841	0.000866	CcSEcCtD
Zuclopenthixol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000862	CcSEcCtD
Zuclopenthixol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000836	0.00086	CcSEcCtD
Zuclopenthixol—Vomiting—Azathioprine—systemic scleroderma	0.000834	0.000858	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—systemic scleroderma	0.000831	0.000856	CcSEcCtD
Zuclopenthixol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000831	0.000855	CcSEcCtD
Zuclopenthixol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000829	0.000853	CcSEcCtD
Zuclopenthixol—Drowsiness—Methotrexate—systemic scleroderma	0.000828	0.000852	CcSEcCtD
Zuclopenthixol—Rash—Azathioprine—systemic scleroderma	0.000827	0.000851	CcSEcCtD
Zuclopenthixol—Dermatitis—Azathioprine—systemic scleroderma	0.000826	0.00085	CcSEcCtD
Zuclopenthixol—Headache—Azathioprine—systemic scleroderma	0.000822	0.000846	CcSEcCtD
Zuclopenthixol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000821	0.000845	CcSEcCtD
Zuclopenthixol—Dizziness—Leflunomide—systemic scleroderma	0.000819	0.000843	CcSEcCtD
Zuclopenthixol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000811	0.000834	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000808	0.000832	CcSEcCtD
Zuclopenthixol—Angiopathy—Prednisone—systemic scleroderma	0.000807	0.000831	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000805	0.000828	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—systemic scleroderma	0.000804	0.000827	CcSEcCtD
Zuclopenthixol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000821	CcSEcCtD
Zuclopenthixol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000821	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—systemic scleroderma	0.000795	0.000818	CcSEcCtD
Zuclopenthixol—Sweating—Methotrexate—systemic scleroderma	0.000794	0.000817	CcSEcCtD
Zuclopenthixol—HTR2A—connective tissue—systemic scleroderma	0.000792	0.028	CbGeAlD
Zuclopenthixol—Vomiting—Leflunomide—systemic scleroderma	0.000787	0.00081	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000784	0.000807	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000783	0.000806	CcSEcCtD
Zuclopenthixol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000781	0.000804	CcSEcCtD
Zuclopenthixol—Rash—Leflunomide—systemic scleroderma	0.000781	0.000804	CcSEcCtD
Zuclopenthixol—Dermatitis—Leflunomide—systemic scleroderma	0.00078	0.000803	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—systemic scleroderma	0.000779	0.000802	CcSEcCtD
Zuclopenthixol—Nausea—Azathioprine—systemic scleroderma	0.000779	0.000802	CcSEcCtD
Zuclopenthixol—Headache—Leflunomide—systemic scleroderma	0.000776	0.000798	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—systemic scleroderma	0.000774	0.000797	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—systemic scleroderma	0.000774	0.000797	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000773	0.000795	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000791	CcSEcCtD
Zuclopenthixol—Asthenia—Lisinopril—systemic scleroderma	0.000764	0.000786	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000762	0.000785	CcSEcCtD
Zuclopenthixol—Pruritus—Lisinopril—systemic scleroderma	0.000753	0.000775	CcSEcCtD
Zuclopenthixol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000751	0.000773	CcSEcCtD
Zuclopenthixol—Rash—Mycophenolic acid—systemic scleroderma	0.000745	0.000767	CcSEcCtD
Zuclopenthixol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000744	0.000766	CcSEcCtD
Zuclopenthixol—Headache—Mycophenolic acid—systemic scleroderma	0.00074	0.000762	CcSEcCtD
Zuclopenthixol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000759	CcSEcCtD
Zuclopenthixol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000759	CcSEcCtD
Zuclopenthixol—Nausea—Leflunomide—systemic scleroderma	0.000736	0.000757	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000734	0.000756	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—systemic scleroderma	0.00073	0.000751	CcSEcCtD
Zuclopenthixol—Urethral disorder—Methotrexate—systemic scleroderma	0.000729	0.00075	CcSEcCtD
Zuclopenthixol—Diarrhoea—Lisinopril—systemic scleroderma	0.000728	0.000749	CcSEcCtD
Zuclopenthixol—HTR2A—smooth muscle tissue—systemic scleroderma	0.000724	0.0256	CbGeAlD
Zuclopenthixol—DRD2—lung—systemic scleroderma	0.000724	0.0256	CbGeAlD
Zuclopenthixol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000719	0.000739	CcSEcCtD
Zuclopenthixol—Visual impairment—Methotrexate—systemic scleroderma	0.000716	0.000737	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—systemic scleroderma	0.000712	0.000732	CcSEcCtD
Zuclopenthixol—Dizziness—Lisinopril—systemic scleroderma	0.000704	0.000724	CcSEcCtD
Zuclopenthixol—Nausea—Mycophenolic acid—systemic scleroderma	0.000702	0.000722	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—systemic scleroderma	0.000698	0.000719	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—systemic scleroderma	0.000696	0.000716	CcSEcCtD
Zuclopenthixol—Eye disorder—Methotrexate—systemic scleroderma	0.000695	0.000715	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—systemic scleroderma	0.000694	0.000715	CcSEcCtD
Zuclopenthixol—Tinnitus—Methotrexate—systemic scleroderma	0.000693	0.000713	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00069	0.00071	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000687	0.000707	CcSEcCtD
Zuclopenthixol—HRH1—digestive system—systemic scleroderma	0.000685	0.0242	CbGeAlD
Zuclopenthixol—Loss of consciousness—Prednisone—systemic scleroderma	0.000681	0.0007	CcSEcCtD
Zuclopenthixol—Vomiting—Lisinopril—systemic scleroderma	0.000677	0.000696	CcSEcCtD
Zuclopenthixol—Angiopathy—Methotrexate—systemic scleroderma	0.000675	0.000694	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methotrexate—systemic scleroderma	0.000672	0.000691	CcSEcCtD
Zuclopenthixol—Rash—Lisinopril—systemic scleroderma	0.000671	0.000691	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—systemic scleroderma	0.000671	0.000691	CcSEcCtD
Zuclopenthixol—Dermatitis—Lisinopril—systemic scleroderma	0.00067	0.00069	CcSEcCtD
Zuclopenthixol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000669	0.000688	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—systemic scleroderma	0.000669	0.000688	CcSEcCtD
Zuclopenthixol—Headache—Lisinopril—systemic scleroderma	0.000667	0.000686	CcSEcCtD
Zuclopenthixol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00066	0.000679	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—systemic scleroderma	0.000659	0.000679	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—systemic scleroderma	0.000657	0.000676	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000655	0.000674	CcSEcCtD
Zuclopenthixol—HRH1—tendon—systemic scleroderma	0.000652	0.023	CbGeAlD
Zuclopenthixol—Discomfort—Prednisone—systemic scleroderma	0.000651	0.00067	CcSEcCtD
Zuclopenthixol—Mental disorder—Methotrexate—systemic scleroderma	0.000651	0.00067	CcSEcCtD
Zuclopenthixol—Erythema—Methotrexate—systemic scleroderma	0.000647	0.000666	CcSEcCtD
Zuclopenthixol—Malnutrition—Methotrexate—systemic scleroderma	0.000647	0.000666	CcSEcCtD
Zuclopenthixol—ADRA2A—tendon—systemic scleroderma	0.00064	0.0226	CbGeAlD
Zuclopenthixol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000638	0.000657	CcSEcCtD
Zuclopenthixol—Nausea—Lisinopril—systemic scleroderma	0.000632	0.000651	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000632	0.00065	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—systemic scleroderma	0.000622	0.00064	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—systemic scleroderma	0.00062	0.000638	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—systemic scleroderma	0.000617	0.000635	CcSEcCtD
Zuclopenthixol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000617	0.000635	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—systemic scleroderma	0.000614	0.000632	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000611	0.000629	CcSEcCtD
Zuclopenthixol—Vision blurred—Methotrexate—systemic scleroderma	0.00061	0.000628	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—systemic scleroderma	0.000602	0.00062	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.0006	0.000618	CcSEcCtD
Zuclopenthixol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00061	CcSEcCtD
Zuclopenthixol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000605	CcSEcCtD
Zuclopenthixol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000587	0.000604	CcSEcCtD
Zuclopenthixol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000584	0.000601	CcSEcCtD
Zuclopenthixol—Malaise—Methotrexate—systemic scleroderma	0.000584	0.000601	CcSEcCtD
Zuclopenthixol—Vertigo—Methotrexate—systemic scleroderma	0.000581	0.000598	CcSEcCtD
Zuclopenthixol—Leukopenia—Methotrexate—systemic scleroderma	0.000579	0.000596	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000576	0.000593	CcSEcCtD
Zuclopenthixol—HTR2A—digestive system—systemic scleroderma	0.000572	0.0202	CbGeAlD
Zuclopenthixol—HRH1—lung—systemic scleroderma	0.000572	0.0202	CbGeAlD
Zuclopenthixol—Insomnia—Prednisone—systemic scleroderma	0.000572	0.000588	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—systemic scleroderma	0.000568	0.000584	CcSEcCtD
Zuclopenthixol—ADRA2A—lung—systemic scleroderma	0.000562	0.0198	CbGeAlD
Zuclopenthixol—Convulsion—Methotrexate—systemic scleroderma	0.000561	0.000577	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—systemic scleroderma	0.000556	0.000573	CcSEcCtD
Zuclopenthixol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00057	CcSEcCtD
Zuclopenthixol—Myalgia—Methotrexate—systemic scleroderma	0.000551	0.000567	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—systemic scleroderma	0.000549	0.000565	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000547	0.000563	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—systemic scleroderma	0.000545	0.000561	CcSEcCtD
Zuclopenthixol—Discomfort—Methotrexate—systemic scleroderma	0.000544	0.00056	CcSEcCtD
Zuclopenthixol—HTR2A—tendon—systemic scleroderma	0.000544	0.0192	CbGeAlD
Zuclopenthixol—Constipation—Prednisone—systemic scleroderma	0.00054	0.000556	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000528	0.000544	CcSEcCtD
Zuclopenthixol—CYP2D6—digestive system—systemic scleroderma	0.000521	0.0184	CbGeAlD
Zuclopenthixol—Feeling abnormal—Prednisone—systemic scleroderma	0.000521	0.000536	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000518	0.000533	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000517	0.000532	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000517	0.000532	CcSEcCtD
Zuclopenthixol—Skin disorder—Methotrexate—systemic scleroderma	0.000513	0.000528	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000511	0.000526	CcSEcCtD
Zuclopenthixol—Anorexia—Methotrexate—systemic scleroderma	0.000503	0.000518	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—systemic scleroderma	0.0005	0.000514	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—systemic scleroderma	0.0005	0.000514	CcSEcCtD
Zuclopenthixol—Hypotension—Methotrexate—systemic scleroderma	0.000494	0.000508	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000481	0.000495	CcSEcCtD
Zuclopenthixol—Insomnia—Methotrexate—systemic scleroderma	0.000478	0.000492	CcSEcCtD
Zuclopenthixol—HTR2A—lung—systemic scleroderma	0.000478	0.0169	CbGeAlD
Zuclopenthixol—Paraesthesia—Methotrexate—systemic scleroderma	0.000474	0.000488	CcSEcCtD
Zuclopenthixol—Dyspnoea—Methotrexate—systemic scleroderma	0.000471	0.000485	CcSEcCtD
Zuclopenthixol—Somnolence—Methotrexate—systemic scleroderma	0.00047	0.000483	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—systemic scleroderma	0.000466	0.000479	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methotrexate—systemic scleroderma	0.000465	0.000479	CcSEcCtD
Zuclopenthixol—Decreased appetite—Methotrexate—systemic scleroderma	0.000459	0.000473	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000456	0.000469	CcSEcCtD
Zuclopenthixol—Fatigue—Methotrexate—systemic scleroderma	0.000455	0.000469	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—systemic scleroderma	0.000453	0.000467	CcSEcCtD
Zuclopenthixol—Pain—Methotrexate—systemic scleroderma	0.000452	0.000465	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—systemic scleroderma	0.000447	0.00046	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000435	0.000448	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—systemic scleroderma	0.000432	0.000445	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000432	0.000445	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—systemic scleroderma	0.000418	0.00043	CcSEcCtD
Zuclopenthixol—Body temperature increased—Methotrexate—systemic scleroderma	0.000418	0.00043	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methotrexate—systemic scleroderma	0.000418	0.00043	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—systemic scleroderma	0.000402	0.000414	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—systemic scleroderma	0.000399	0.00041	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—systemic scleroderma	0.000398	0.00041	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—systemic scleroderma	0.000396	0.000407	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000389	0.0004	CcSEcCtD
Zuclopenthixol—Asthenia—Methotrexate—systemic scleroderma	0.000379	0.00039	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—systemic scleroderma	0.000375	0.000386	CcSEcCtD
Zuclopenthixol—Pruritus—Methotrexate—systemic scleroderma	0.000374	0.000385	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methotrexate—systemic scleroderma	0.000361	0.000372	CcSEcCtD
Zuclopenthixol—Dizziness—Methotrexate—systemic scleroderma	0.000349	0.000359	CcSEcCtD
Zuclopenthixol—Vomiting—Methotrexate—systemic scleroderma	0.000336	0.000346	CcSEcCtD
Zuclopenthixol—Rash—Methotrexate—systemic scleroderma	0.000333	0.000343	CcSEcCtD
Zuclopenthixol—Dermatitis—Methotrexate—systemic scleroderma	0.000333	0.000342	CcSEcCtD
Zuclopenthixol—Headache—Methotrexate—systemic scleroderma	0.000331	0.000341	CcSEcCtD
Zuclopenthixol—Nausea—Methotrexate—systemic scleroderma	0.000314	0.000323	CcSEcCtD
